Warning: The NCBI web site requires JavaScript to function. more...
Chabouni H, Ben Jomaa L, Chaabouni M, Mrad R, Kaabachi N, Françoise Ben Dridi M, Tebib N, Saad A, Elghazel H, Gribaa M, Hadj Slama FB, Zemni R, Miled A, Salima F, Essoussi AS, Souyah N, Fakhfakh F, Abdelhak S, Kamoun H, Belguith N, Kamoun N, Fendri N, Luhichi N, Triki C, Kamoun F, Makni Ayedi F.
Laboratoire de Génétique Moléculaire Humaine, Faculté de Médecine de Sfax, Université de Sfax, Tunisia. nourhene.fendri@gmail.com
Rett syndrome is an X-linked dominant disorder caused frequently by mutations in the methyl-CpG-binding protein 2 gene (MECP2). Rett patients present an apparently normal psychomotor development during the first 6-18 months of life. Thereafter, they show a short period of developmental stagnation followed by a rapid regression in language and motor development. The aim of this study was to perform a mutational analysis of the MECP2 gene in a classical Rett patient by sequencing the corresponding gene and modeling the found variants. The results showed the presence of a double-mutation: a new and de novo mutation c.535C>T (p.P179S) and the common c.763C>T (p.R255X) transition of the MECP2 gene. The p.P179S mutation was located in a conserved amino acid in CRIR domain (corepressor interacting region). Modeling results showed that the P179S transition could change local electrostatic properties by adding a negative charge due to serine hydroxyl group of this region of MeCP2 which may affect the function and stability of the protein. The p.R255X mutation is located in TRD-NLS domain (transcription repression domain-nuclear localization signal) of MeCP2 protein.
Published by Elsevier Inc.
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on